Cargando…

Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018

What is already known about this topic? Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (1,2). What is added by this report? In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shuaibing, Ren, Xiang, Zhang, Cuihong, Geng, Mengjie, Zhu, Yuliang, Shi, Lusha, Zhang, Lijie, Li, Zhongjie, Wang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422198/
https://www.ncbi.nlm.nih.gov/pubmed/34594603
_version_ 1783749241722634240
author Dong, Shuaibing
Ren, Xiang
Zhang, Cuihong
Geng, Mengjie
Zhu, Yuliang
Shi, Lusha
Zhang, Lijie
Li, Zhongjie
Wang, Liping
author_facet Dong, Shuaibing
Ren, Xiang
Zhang, Cuihong
Geng, Mengjie
Zhu, Yuliang
Shi, Lusha
Zhang, Lijie
Li, Zhongjie
Wang, Liping
author_sort Dong, Shuaibing
collection PubMed
description What is already known about this topic? Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (1,2). What is added by this report? In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 population, an increase of 12.88% compared with the average rate between 2015–2017. The five notifiable diseases with the highest reported morbidity were hand, foot, and mouth disease (HFMD), infectious diarrhea, hepatitis B, tuberculosis, and influenza. The five regions with the highest reported morbidity of infectious diseases were Zhejiang Province, Guangxi Autonomous Region, Guangdong Province, Beijing Municipality, and Xinjiang Autonomous Region. What are the implications for public health practice? Evidence on notifiable disease morbidity trends and changing epidemiology should help disease control and prevention agencies and medical institutions direct their response and prevention efforts. In addition, this report demonstrates the continued need for surveillance systems and high-quality data to identify focal points for disease control.
format Online
Article
Text
id pubmed-8422198
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-84221982021-09-29 Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 Dong, Shuaibing Ren, Xiang Zhang, Cuihong Geng, Mengjie Zhu, Yuliang Shi, Lusha Zhang, Lijie Li, Zhongjie Wang, Liping China CDC Wkly Vital Surveillances What is already known about this topic? Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (1,2). What is added by this report? In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 population, an increase of 12.88% compared with the average rate between 2015–2017. The five notifiable diseases with the highest reported morbidity were hand, foot, and mouth disease (HFMD), infectious diarrhea, hepatitis B, tuberculosis, and influenza. The five regions with the highest reported morbidity of infectious diseases were Zhejiang Province, Guangxi Autonomous Region, Guangdong Province, Beijing Municipality, and Xinjiang Autonomous Region. What are the implications for public health practice? Evidence on notifiable disease morbidity trends and changing epidemiology should help disease control and prevention agencies and medical institutions direct their response and prevention efforts. In addition, this report demonstrates the continued need for surveillance systems and high-quality data to identify focal points for disease control. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2019-12 /pmc/articles/PMC8422198/ /pubmed/34594603 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2019 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Vital Surveillances
Dong, Shuaibing
Ren, Xiang
Zhang, Cuihong
Geng, Mengjie
Zhu, Yuliang
Shi, Lusha
Zhang, Lijie
Li, Zhongjie
Wang, Liping
Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
title Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
title_full Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
title_fullStr Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
title_full_unstemmed Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
title_short Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018
title_sort morbidity analysis of the notifiable infectious diseases in china, 2018
topic Vital Surveillances
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422198/
https://www.ncbi.nlm.nih.gov/pubmed/34594603
work_keys_str_mv AT dongshuaibing morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT renxiang morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT zhangcuihong morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT gengmengjie morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT zhuyuliang morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT shilusha morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT zhanglijie morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT lizhongjie morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018
AT wangliping morbidityanalysisofthenotifiableinfectiousdiseasesinchina2018